Skip to content
Stock screener

BMY Bristol Myers Squibb Co stock chart & analysis

Conviction 57HealthcareScan · Fri, Nov 6, 2026

Bristol Myers Squibb Co (BMY) closed at $62.14 (-1.57%) on Nov 6, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 51, RS Rating 86, -9.5% from its 52-week high, +15.2% year to date. Sector: Healthcare · Pharmaceutical Preparations.

BMY$62.14-1.57%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
Loading chart…
Bristol Myers Squibb CoPharmaceutical Preparationswww.bms.com ↗
Price62.14
Change-1.57%
Gap-2.50%
Rel volume1.13×
Avg volume12.35M
Avg $ vol751.48M
SMA 2061.09
SMA 5062.35
SMA 20060.14
Price vs 50-0.33%
Price vs 200+3.32%
MA stackmixed
50/200 cross—
Supertrendup · 58.73
RSI (14)51
MACD hist0.30
MACD cross—
Stoch %K / %D40 / 69
ADX (14)17
+DI / −DI29 / 22
RSI divergence—
MACD divergence—
ATR %2.89%
ADR %2.96%
52w high68.64
52w low45.27
From 52w high-9.47%
Above 52w low+37.28%
New 52w highNo
SqueezeOff
Bollinger width12.09%
%B0.64
Donchian pos63.79%
Donchian high65.54
Donchian low56.15
AVWAP (52w high)62.42
vs AVWAP high-0.46%
AVWAP (52w low)58.45
vs AVWAP low+6.32%
OBV trendFlat
Chaikin MF (20)-0.07
Today vs 20d1.13×
Avg vol (14d)11.03M
Avg vol (20d)12.35M
Avg $ vol (20d)751.48M
Market cap127.02B
RS Rating86 / 99
RS 3m (vs SPY)+0.70%
RS 6m (vs SPY)+10.95%
RS line new highNo
Trend template7/8
Technical rank79.1
1 week-0.54%
1 month+4.30%
3 months-4.16%
6 months+10.65%
1 year+33.72%
YTD+15.20%
P/E18.01
P/B5.43
P/S2.64
P/FCF9.89
EPS3.46
Div yield3.97%
ROE30.14%
ROA7.95%
Debt/Eq1.82
Current1.59
EV/EBITDA—
Gross margin71.08%
Net margin14.64%
Rev growth-0.22%
EPS growth178.83%
Price target65.74
Target upside5.79%
Analyst ratingHold
Institutional92.00%
Ent. value160.06B
Revenue13.07B
Net income2.16B
Gross profit8.92B
Free cash flow12.85B
IndustryPharmaceutical Preparations
ExchangeNYSE
Shares out2.04B
Employees32.5K
ListedMon, Jun 23, 1952
Free float2.04B
Float %99.9%
Short interest—
Days to cover—
Short volume46.8%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est$1.35 vs $1.21
Last surprise+11.6% beat
Setup gradeD
Conviction57 / 100
Pattern quality—
Tech rank79.1 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance63.92
Support57.24
Days since event—
Candle confirm—

Financials as of Wed, Sep 30, 2026 · quarterly.

BMY technical analysis

Trend

BMY's moving averages are mixed — no clean uptrend or downtrend. It closed 0.3% below the 50-day ($62.35) and 3.3% above the 200-day ($60.14). ADX(14) at 17 points to a weak trend — more range than direction. It meets 7 of 8 trend-template criteria.

Momentum

RSI(14) is 51, in the bullish half of its range. The MACD histogram is positive. Its RS Rating of 86 puts its weighted 12-month performance ahead of about 86% of the US market.

Volume and volatility

Volume on the latest session ran 1.1× its 20-day average. It trades about $751.5M a day on average. ATR(14) is $1.80, 2.9% of price — its typical daily range. Chaikin Money Flow (-0.07) shows distribution.

Key levels

The chart pattern's support is $57.24 and its resistance $63.92. The 52-week range is $45.27 to $68.64; price is 9.5% below the high and 37.3% above the low. The VWAP anchored at the 52-week high is $62.42, above price.

Performance

BMY returned -0.5% (1 week), +4.3% (1 month), -4.2% (3 months), +10.7% (6 months), +33.7% (1 year), +15.2% (year to date).

About Bristol Myers Squibb Co

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Pharmaceutical Preparations · Listed 1952 · 32,500 employees

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Aug 24 – Oct 16
    6 scans
  2. Breaking out now
    Oct 20
    1 scan

Congress activity

Disclosed STOCK Act trades in BMY · 10 recent

All disclosures →
MemberSideAmount
Thomas H Tuberville
Thomas H Tuberville
senate · traded 2025-04-15
Sell$1K–$15K
Alan Armstrong
Alan Armstrong
senate · R · OK · traded 2026-03-27
Buy$1K–$15K
Mike Kelly
Mike Kelly
house · PA · traded 2026-05-07
Sell$15K–$50K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2025-12-19
Buy$1K–$15K
Julie Johnson
Julie Johnson
house · TX · traded 2025-12-18
Sell$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2025-11-12
Buy$1K–$15K
Valerie Hoyle
Valerie Hoyle
house · D · OR · traded 2024-10-29
Buy$1K–$15K
Julie Johnson
Julie Johnson
house · D · TX · traded 2025-08-14
Sell$1K–$15K
Julia Letlow
Julia Letlow
house · LA · traded 2025-04-28
Sell$1K–$15K
Virginia Foxx
Virginia Foxx
house · R · NC · traded 2025-06-24
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in BMY · open-market 1 sell

InsiderSideShares
Haller Julia A
Director · Common Stock, $0.10 par value · 2026-11-05
Sell3.8K
Lenkowsky Adam
EVP, Chief Commercial Officer · Common Stock, $0.10 par value · 2026-11-03
Exercise7.52K
Lenkowsky Adam
EVP, Chief Commercial Officer · Common Stock, $0.10 par value · 2026-11-03
Tax3.85K
Lenkowsky Adam
EVP, Chief Commercial Officer · Restricted Stock Units · 2026-11-03
Exercise7.52K
BOERNER CHRISTOPHER S.
Chief Executive Officer · Common Stock, $0.10 par value · 2026-11-01
Exercise2.96K
BOERNER CHRISTOPHER S.
Chief Executive Officer · Common Stock, $0.10 par value · 2026-11-01
Acquire406
BOERNER CHRISTOPHER S.
Chief Executive Officer · Common Stock, $0.10 par value · 2026-11-01
Tax1.72K
BOERNER CHRISTOPHER S.
Chief Executive Officer · Market Share Units · 2026-11-01
Exercise2.96K
Meyers Gregory Scott
EVP, Chief Digital & Tech Off. · Common Stock, $0.10 par value · 2026-11-01
Exercise6.28K
Meyers Gregory Scott
EVP, Chief Digital & Tech Off. · Common Stock, $0.10 par value · 2026-11-01
Tax2.67K

SEC filings

EDGAR filings in BMY · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.